Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,513 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departments.
Haukoos JS, Rowan SE, Galbraith JW, Rothman RE, Hsieh YH, Hopkins E, Houk RA, Toerper MF, Kamis KF, Morgan JR, Linas BP, Al-Tayyib AA, Gardner EM, Lyons MS, Sabel AL, White DAE, Wyles DL; DETECT Hep C Trials Investigators. Haukoos JS, et al. Trials. 2022 Apr 25;23(1):354. doi: 10.1186/s13063-022-06265-1. Trials. 2022. PMID: 35468807 Free PMC article. Clinical Trial.
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis C.
Rowan SE, Haukoos J, Kamis KF, Hopkins E, Gravitz S, Lyle C, Al-Tayyib AA, Gardner EM, Galbraith JW, Hsieh YH, Lyons MS, Rothman RE, White DAE, Morgan JR, Linas BP, Sabel AL, Wyles DL; DETECT Hep C Trials Investigators. Rowan SE, et al. Trials. 2023 Jan 27;24(1):63. doi: 10.1186/s13063-022-07018-w. Trials. 2023. PMID: 36707909 Free PMC article. Clinical Trial.
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study.
Makker V, Perez-Fidalgo JA, Valabrega G, Hamilton E, Van Gorp T, Sehouli J, Regináčová K, Richardson DL, Perri T, Oza AM, Miller DS, Alía EMG, De Giorgi U, Henry S, Spitz DL, Wimberger P, Bednaříková M, Chon HS, Martínez-Garcia J, Pisano C, Berek JS, Romero I, Scambia G, Fariñas-Madrid L, Buscema J, Schochter F, Li K, Kalyanapu P, Walker CJ, Vergote I. Makker V, et al. Among authors: henry s. Gynecol Oncol. 2024 Jun 3:S0090-8258(24)00234-8. doi: 10.1016/j.ygyno.2024.05.016. Online ahead of print. Gynecol Oncol. 2024. PMID: 38834399
The New South Wales Mouse Plague 2020-2021: A One Health description.
White J, Taylor J, Brown PR, Henry S, Carter L, Mankad A, Chang WS, Stanley P, Collins K, Durrheim DN, Thompson K. White J, et al. Among authors: henry s. One Health. 2024 May 9;18:100753. doi: 10.1016/j.onehlt.2024.100753. eCollection 2024 Jun. One Health. 2024. PMID: 38798736 Free PMC article.
Tuft cell acetylcholine is released into the gut lumen to promote anti-helminth immunity.
Ndjim M, Gasmi I, Herbert F, Joséphine C, Bas J, Lamrani A, Coutry N, Henry S, Zimmermann VS, Dardalhon V, Campillo Poveda M, Turtoi E, Thirard S, Forichon L, Giordano A, Ciancia C, Homayed Z, Pannequin J, Britton C, Devaney E, McNeilly TN, Berrard S, Turtoi A, Maizels RM, Gerbe F, Jay P. Ndjim M, et al. Among authors: henry s. Immunity. 2024 May 9:S1074-7613(24)00223-1. doi: 10.1016/j.immuni.2024.04.018. Online ahead of print. Immunity. 2024. PMID: 38744292 Free article.
1,513 results